BLUE - long - possible bottom / gap play
bluebird bio Inc is a biotechnology company engaged in researching, developing, and commercializing potentially curative gene therapies for severe genetic diseases based on its proprietary lentiviral vector (LVV) gene addition platform. The Company operates in a single segment, focusing on researching, developing and commercializing potentially transformative gene therapies for severe genetic diseases.
This is not a financial advice!
Couldn't find any catalyst that bothers me a bit to be honest.
Biotechs are pretty hot recently
We need to stay in a bullish overal sentiment of the market. If we see a corretion, this play might doesn't work.
14.49% short float
Block buys and Passive Stakes
Keep an eye on 1.50 key level, needs to get broken for a further upmove. You could wait for an entry until 1.50 gets broken and watch the price action there.
SL under 1.0
TP approx. 2.20
Most info on the chart.
Trade carefully!
This is not a financial advice!
Couldn't find any catalyst that bothers me a bit to be honest.
Biotechs are pretty hot recently
We need to stay in a bullish overal sentiment of the market. If we see a corretion, this play might doesn't work.
14.49% short float
Block buys and Passive Stakes
Keep an eye on 1.50 key level, needs to get broken for a further upmove. You could wait for an entry until 1.50 gets broken and watch the price action there.
SL under 1.0
TP approx. 2.20
Most info on the chart.
Trade carefully!
Comentarios:
Bluebird secures up to $175M financing amid gene therapy launches
Comentarios:
Monday March 25, 2024
02:52:59PM
BLUE
Block Trade: BLUE 620,700 @ $1.365
Signals
Friday March 15, 2024
04:14:34PM
BLUE
Block Trade: BLUE 574,548 @ $1.42
02:52:59PM
BLUE
Block Trade: BLUE 620,700 @ $1.365
Signals
Friday March 15, 2024
04:14:34PM
BLUE
Block Trade: BLUE 574,548 @ $1.42